Gardner Law Is Growing

August 18, 2025

Gardner Law is pleased to announce the addition of two new team members: William “Billy” Delfs, Associate Attorney and Charlie Zamastil, Marketing Manager. In response to rising client demand for sophisticated regulatory support, these new hires enhance both our depth and scope.

“Our growth reflects the trust our clients place in us. Billy and Charlie strengthen our ability to deliver the practical, business-minded counsel FDA-regulated companies need to succeed.”
— Mark Gardner, Managing Partner, Gardner Law

Expanding Legal and Regulatory Expertise

Billy joins Gardner Law with more than 20 years of experience in the medical device, in vitro diagnostics, and life sciences sectors. In addition to his regulatory expertise, Billy has deep experience in quality systems, supporting companies through FDA audits and inspections, preparing responses to 483 observations, managing recalls, and crafting strategies to mitigate enforcement actions. He has guided companies through complex FDA submissions, CE-mark approvals, and EU MDR/IVDR compliance. His background in engineering and regulatory affairs allows him to bridge technical detail with legal strategy—an invaluable asset for clients facing high-stakes regulatory and quality challenges.

“Billy’s combination of technical know-how and regulatory depth enhances our ability to serve medtech and biotech companies and innovators at every stage of the product lifecycle.”
Amanda Johnston, Partner, Gardner Law

Strengthening Client Engagement and Communication

Charlie brings a complementary dimension to the team. With a background in marketing, strategy, and commercialization, he has worked across the medical device and food industries. At Gardner Law, Charlie leads marketing and communications, ensuring our thought leadership, events, and client resources reach our audience with relevance and clarity.

Growth Driven by Client Needs

The addition of Billy and Charlie reflects Gardner Law’s continued growth and the confidence our clients place in us. As demand for actionable guidance in FDA‑regulated industries increases, we are expanding our team to provide even greater depth and broader scope of service.

Our growth is a direct result of doing what we do best: helping companies move forward with confidence. With Billy and Charlie on board, Gardner Law is better positioned than ever to guide clients through regulatory, compliance, privacy, litigation, and commercial challenges.